Nexnos Pharma Limited, a active public limited company, was established on 14 August 2007 in Chittorgarh, Rajasthan, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U24100RJ2007PLC024845. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹1.91 Cr.
Formerly known as Asnani Brokers Private Limited, Nexnos Pharma Limited. It upholds a compliant status. Its leadership includes Kamal Asnani (Director), Vinod Asnani (Director), Rajesh Peswani (Director). Past directors included Rameshchandra. It holds ₹12.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 103, Pratap Nagar, Sindhi Colony, Chittorgarh, Rajasthan, 312001.
U24100RJ2007PLC024845
024845
14 August 2007
₹5.00 Cr
₹1.91 Cr
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Nexnos Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamal Asnani | Director | 14 Aug 2007 | Current |
| Vinod Asnani | Director | 14 Aug 2007 | Current |
| Rajesh Peswani | Director | 20 Mar 2024 | Current |
| Rameshchandra | Director | 03 May 2023 | Current |
| Ashish Kumar Agrawal | Director | 03 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Nexnos Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹120,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2024 | Others | ₹12.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nexnos Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nexnos Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexnos Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 12.00 Cr registered on 19 Jun 2024 with Charge ID 100936082 was modified on 07 Nov 2024. was recorded as a recent event.
Progress on Nexnos Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with Others amounted to Rs. 12.00 Cr with Charge ID 100936082 was registered on 19 Jun 2024. was recorded as a recent event.
Nexnos Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was recorded as a recent event.
Progress on Rajesh Peswani was appointed as a Director was appointed as a Director on 20 Mar 2024 & has been associated with this company since 1 year 8 months . was documented.
The activity Rameshchandra was appointed as a Director was appointed as a Director on 03 May 2023 & has been associated with this company since 2 years 6 months . was completed.
The CIN of Nexnos Pharma Limited is U24100RJ2007PLC024845.
Nexnos Pharma Limited is headquartered at 103, Pratap Nagar, Sindhi Colony, Chittorgarh, Rajasthan, 312001.
Nexnos Pharma Limited was incorporated on 14 August 2007.
The current directors of Nexnos Pharma Limited are
The primary industry of Nexnos Pharma Limited is Trade.
Nexnos Pharma Limited is unlisted.
The authorized capital of Nexnos Pharma Limited is ₹5.00 Cr, and the paid-up capital is ₹1.91 Cr.
The compliance status of Nexnos Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX